The Association between Psoriasis Area and Severity Index and Cardiovascular Risk Factor in Korean Psoriasis Patients
2
조회
0
다운로드
1
인용
0
참고문헌
키워드
초록
Background: Psoriasis is associated with increased risk of cardiovascular morbidities, especially in severe cases. Severity of the disease has been known to be associated with higher prevalence of these risk factors. However, in the absence of robust measurements, studies to date relied mostly on treatment spectrum as a proxy for the severity. Objective: To evaluate the relationship between psoriasis area and severity index (PASI) and cardiovascular risk factors in Korean patients. Methods: Presence of diabetes mellitus (DM), hypertension, smoking history was surveyed through questionnaires and serum lipid profile analysis were done after fasting overnight. The severity of psoriasis was assessed using PASI scores: mild, ＜10; moderate to severe, ≥10. Cardiovascular risk factors such as smoking, hypertension, diabetes and dyslipidemia were compared between the mild group and moderate to severe group. The prevalence of diabetes and hypertension was compared among these two groups of psoriasis patients and the general population based control; age and gender were matched among three groups accordingly prior to analysis. Results: A total of 256 patients with plaque type psoriasis were included. Between mild group and moderate to severe group, significant differences of cardiovascular risk factors including lipid profile were not discovered except in triglyceride level. Comparing to general population, prevalence of diabetes was found significantly higher in psoriasis patients while that of hypertension was similar. Conclusion: Our results suggest that among cardiovascular risks, presence of DM and triglyceride level seem to be associated with the presence of psoriasis in Korean psoriasis patients, while other factors may not contribute meaningfully.
Abstract
Background: Psoriasis is associated with increased risk of cardiovascular morbidities, especially in severe cases. Severity of the disease has been known to be associated with higher prevalence of these risk factors. However, in the absence of robust measurements, studies to date relied mostly on treatment spectrum as a proxy for the severity. Objective: To evaluate the relationship between psoriasis area and severity index (PASI) and cardiovascular risk factors in Korean patients. Methods: Presence of diabetes mellitus (DM), hypertension, smoking history was surveyed through questionnaires and serum lipid profile analysis were done after fasting overnight. The severity of psoriasis was assessed using PASI scores: mild, ＜10; moderate to severe, ≥10. Cardiovascular risk factors such as smoking, hypertension, diabetes and dyslipidemia were compared between the mild group and moderate to severe group. The prevalence of diabetes and hypertension was compared among these two groups of psoriasis patients and the general population based control; age and gender were matched among three groups accordingly prior to analysis. Results: A total of 256 patients with plaque type psoriasis were included. Between mild group and moderate to severe group, significant differences of cardiovascular risk factors including lipid profile were not discovered except in triglyceride level. Comparing to general population, prevalence of diabetes was found significantly higher in psoriasis patients while that of hypertension was similar. Conclusion: Our results suggest that among cardiovascular risks, presence of DM and triglyceride level seem to be associated with the presence of psoriasis in Korean psoriasis patients, while other factors may not contribute meaningfully.
참고문헌 (15)
- Hugh J., "From the Medical Board of the National Psoriasis Foundation : the risk of cardiovascular disease in individuals with psoriasis and the potential impact of current therapies", J Am Acad Dermatol, 70, pp.168~177 (2014)
- Churton S., "Does treatment of psoriasis reduce the risk of cardiovascular disease?", Drugs, 74, pp.169~182 (2014)
- Korea Centers for Disease Control and Prevention, "The Sixth Korea National Health and Nutrition Examination Survey(KNHANES VI-1)", Korea Centers for Disease Control and Prevention, ~ (2013)
- Shlyankevich J., "Accumulating evidence for the association and shared pathogenic mechanisms between psoriasis and cardiovascular-related comorbidities", Am J Med, 127, pp.1148~1153 (2014)
- Armstrong AW., "Psoriasis and the risk of diabetes mellitus : a systematic review and meta-analysis", JAMA Dermatol, 149, pp.84~91 (2013)
- Miller IM., "Meta-analysis of psoriasis, cardiovascular disease, and associated risk factors", J Am Acad Dermatol, 69, pp.1014~1024 (2013)
- Armstrong AW., "Psoriasis and metabolic syndrome : a systematic review and meta-analysis of observational studies", J Am Acad Dermatol, 68, pp.654~662 (2013)
- Gun-Wook Kim, "Analysis of Cardiovascular Risk Factors and Metabolic Syndrome in Korean Patients with Psoriasis", Annals of Dermatology, 24(1), pp.11~15 (2012), 대한피부과학회
- 최우진, "Association between Psoriasis and Cardiovascular Risk Factors in Korean Patients", Annals of Dermatology, 22(3), pp.300~306 (2010), 대한피부과학회
- Gladman DD., "Cardiovascular morbidity in psoriatic arthritis", Ann Rheum Dis, 68, pp.1131~1135 (2009)
- Fernández-Torres R., "Psoriasis and cardiovascular risk. Assessment by different cardiovascular risk scores", J Eur Acad Dermatol Venereol, 27, pp.1566~1570 (2013)
- Gisondi P., "Prevalence of metabolic syndrome in patients with psoriasis : a hospital-based case-control study", Br J Dermatol, 157, pp.68~73 (2007)
- Gyldenløve M., "Patients with psoriasis are insulin resistant", J Am Acad Dermatol, 72, pp.599~605 (2015)
- Deshmukh M., "Antihypertensive medications and their effects on lipid metabolism", Curr Diab Rep, 8, pp.214~220 (2008)
- Keidan B., "Plasma lipids and antidiabetic agents : a brief overview", Br J Diabetes Vasc Dis, 2, pp.40~43 (2002)